Papers
1
Total Citations
3
H-Index
1
About
Lunbin Wang is a surgical oncologist whose research focuses on advancing the treatment of hepatobiliary malignancies, particularly cholangiocarcinoma. Wang’s most-cited work, a 2024 systematic review and meta-analysis comparing robotic-assisted radical resection to open surgery for cholangiocarcinoma, has already garnered 3 citations—a strong early indicator of its clinical relevance. This study critically evaluates the safety, efficacy, and oncological outcomes of minimally invasive approaches, offering evidence that could reshape surgical protocols for this challenging cancer. By synthesizing data from multiple centers, Wang provides a nuanced perspective on the trade-offs between robotic precision and traditional open techniques, addressing key questions about lymph node dissection, resection margins, and postoperative recovery. Though early in their career, Wang’s contribution stands out for its rigorous methodology and timely focus on a rapidly evolving field. Their work not only informs surgical decision-making but also highlights the potential of robotic systems to improve patient outcomes in complex hepatobiliary surgery. As robotic-assisted procedures gain traction, Wang’s meta-analysis serves as a foundational reference for clinicians and researchers seeking to optimize cholangiocarcinoma management.
Research Focus
Key Achievements
Top Papers
- 1